Home
/ KRKA
/ Competitors

KRKA Competitors and Similar CompaniesClear all

KRKA's competitors and similar companies include Hikma Pharmaceuticals, Teva, Sun Pharma and Torrent Pharmaceuticals.

	KRKA KRKA is an international generic pharmaceutical company.	Hikma Pharmaceuticals Hikma focuses on a wide range of generic, branded generic and in licensed pharmaceutical products.	Teva Teva is a pharmaceuticals company.	Sun Pharma Sun Pharma (also known as Sun Pharmaceutical Industries) is a specialty generic pharmaceutical company.	Torrent Pharmaceuticals Manufactures wide range of pharmaceutical products.
Founding Date	Founding Date 1954	Founding Date 1978	Founding Date 1901	Founding Date 1983	Founding Date 1971
Type	Type Public	Type Public	Type Private	Type Public	Type Public
Tags	Tags Healthcare pharma	Tags Healthcare pharma	Tags Healthcare pharma	Tags Healthcare drug development pharma	Tags Healthcare pharma
Locations	Locations SI HQ	Locations London, GB HQ Staoueli, DZ Mississauga, CA Boulogne Billancourt, FR Martinsried, DE Pavia, IT Amman, JO see more	Locations HQ	Locations Mumbai, IN HQ Macquarie Park, AU Dhaka, BD Goiânia, BR Goiânia, BR São Paulo, BR Brampton, CA see more	Locations Ahmedabad, IN HQ São Paulo, BR Nürnberg, DE 32 No Market, IN Bengaluru, IN Chennai, IN Dahej, IN see more
Employees	Employees 132,447	Employees 9,500	Employees 29,780	Employees 43,000	Employees 15,718
Financial
Revenue (est.)	Revenue (est.) €2b (FY, 2025)	Revenue (est.) $3.3b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) ₹582.2b (FY, 2026)	Revenue (est.) ₹137.5b (FY, 2026)
Cost of goods	Cost of goods €764m (FY, 2025)	Cost of goods $1.7b (FY, 2025)	Cost of goods N/A	Cost of goods ₹115.4b (FY, 2026)	Cost of goods ₹33.9b (FY, 2026)
Gross profit	Gross profit €1.3b (FY, 2025)	Gross profit $1.7b (FY, 2025)	Gross profit N/A	Gross profit ₹488.9b (FY, 2026)	Gross profit ₹105b (FY, 2026)
Net income	Net income €403.7m (FY, 2025)	Net income $407m (FY, 2025)	Net income N/A	Net income ₹115.6b (FY, 2026)	Net income ₹21.4b (FY, 2026)